The PLX3397 activates the immune response by inhibiting the CSF1/CSF1R pathway in TAMs, further enhancing CD8+ T cell infiltration and reversing tumor immunosuppression (macrophage polarization). The gene discussed is CSF1R; the disease is neoplasm.